5 Followers on Owler

Actuate

is a Texas-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Actuate

is a Texas-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer... Read more
Actuate President & CEO: Daniel M. Schmitt

President & CEO

Daniel M. Schmitt

CEO Approval Rating

89/100

2015

PublicIndependent CompanyNASDAQACTU

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
<$1M
Employees
10
Funding
$96M

News

Conference Presentation
Feb 06, 2025
GlobeNewswire
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
AI
Oct 29, 2024
Yahoo
Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development
Funding
Aug 12, 2024
nasdaq.com
Actuate received $22.4M in IPO Funding

Actuate Competitors

1NexImmune
2TScan
3Kite Pharma
4RayzeBio
5Jounce
6Apexigen
7Merrimack
8Juno Therapeutics
9Inovio
10bluebird bio
Unlock 25 + competitors

Trending Companies